nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenazopyridine—SCN7A—cardiac atrium—thymus cancer	0.0682	0.0741	CbGeAlD
Phenazopyridine—SCN7A—thyroid gland—thymus cancer	0.0574	0.0624	CbGeAlD
Phenazopyridine—SCN2A—hematopoietic system—thymus cancer	0.0555	0.0604	CbGeAlD
Phenazopyridine—SCN10A—hematopoietic system—thymus cancer	0.0535	0.0582	CbGeAlD
Phenazopyridine—SCN9A—pituitary gland—thymus cancer	0.0522	0.0567	CbGeAlD
Phenazopyridine—SCN7A—lung—thymus cancer	0.0521	0.0567	CbGeAlD
Phenazopyridine—SCN4A—pituitary gland—thymus cancer	0.0465	0.0506	CbGeAlD
Phenazopyridine—SCN2A—pituitary gland—thymus cancer	0.0412	0.0448	CbGeAlD
Phenazopyridine—SCN9A—lung—thymus cancer	0.0408	0.0444	CbGeAlD
Phenazopyridine—SCN4A—thyroid gland—thymus cancer	0.0401	0.0436	CbGeAlD
Phenazopyridine—SCN10A—pituitary gland—thymus cancer	0.0397	0.0432	CbGeAlD
Phenazopyridine—SCN10A—lymphoid tissue—thymus cancer	0.0377	0.041	CbGeAlD
Phenazopyridine—SCN5A—cardiac atrium—thymus cancer	0.0369	0.0402	CbGeAlD
Phenazopyridine—SCN3A—pituitary gland—thymus cancer	0.0362	0.0394	CbGeAlD
Phenazopyridine—SCN7A—lymph node—thymus cancer	0.0357	0.0388	CbGeAlD
Phenazopyridine—SCN1A—lung—thymus cancer	0.0351	0.0382	CbGeAlD
Phenazopyridine—SCN3A—bone marrow—thymus cancer	0.0313	0.034	CbGeAlD
Phenazopyridine—SCN3A—thyroid gland—thymus cancer	0.0312	0.0339	CbGeAlD
Phenazopyridine—SCN10A—lung—thymus cancer	0.0311	0.0338	CbGeAlD
Phenazopyridine—SCN3A—lung—thymus cancer	0.0283	0.0308	CbGeAlD
Phenazopyridine—SCN9A—lymph node—thymus cancer	0.0279	0.0304	CbGeAlD
Phenazopyridine—SCN10A—lymph node—thymus cancer	0.0213	0.0231	CbGeAlD
Phenazopyridine—SCN3A—lymph node—thymus cancer	0.0194	0.0211	CbGeAlD
Phenazopyridine—SCN7A—Axon guidance—DPYSL5—thymus cancer	0.00513	0.0821	CbGpPWpGaD
Phenazopyridine—SCN11A—Axon guidance—DPYSL5—thymus cancer	0.00457	0.0732	CbGpPWpGaD
Phenazopyridine—SCN8A—Axon guidance—DPYSL5—thymus cancer	0.00418	0.0669	CbGpPWpGaD
Phenazopyridine—Nephrolithiasis—Octreotide—thymus cancer	0.00375	0.206	CcSEcCtD
Phenazopyridine—SCN7A—Developmental Biology—DPYSL5—thymus cancer	0.00366	0.0586	CbGpPWpGaD
Phenazopyridine—SCN9A—Axon guidance—DPYSL5—thymus cancer	0.00338	0.0541	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—DPYSL5—thymus cancer	0.00326	0.0522	CbGpPWpGaD
Phenazopyridine—SCN3A—Axon guidance—DPYSL5—thymus cancer	0.00323	0.0518	CbGpPWpGaD
Phenazopyridine—SCN2A—Axon guidance—DPYSL5—thymus cancer	0.00311	0.0498	CbGpPWpGaD
Phenazopyridine—SCN4A—Axon guidance—DPYSL5—thymus cancer	0.00311	0.0498	CbGpPWpGaD
Phenazopyridine—SCN1A—Axon guidance—DPYSL5—thymus cancer	0.003	0.048	CbGpPWpGaD
Phenazopyridine—SCN10A—Axon guidance—DPYSL5—thymus cancer	0.003	0.048	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—DPYSL5—thymus cancer	0.00298	0.0478	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—DPYSL5—thymus cancer	0.00241	0.0386	CbGpPWpGaD
Phenazopyridine—Visual disturbance—Octreotide—thymus cancer	0.00231	0.127	CcSEcCtD
Phenazopyridine—SCN3A—Developmental Biology—DPYSL5—thymus cancer	0.00231	0.037	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—DPYSL5—thymus cancer	0.00222	0.0355	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—DPYSL5—thymus cancer	0.00222	0.0355	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—DPYSL5—thymus cancer	0.00214	0.0342	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—DPYSL5—thymus cancer	0.00214	0.0342	CbGpPWpGaD
Phenazopyridine—SCN5A—Axon guidance—DPYSL5—thymus cancer	0.00211	0.0337	CbGpPWpGaD
Phenazopyridine—Jaundice—Octreotide—thymus cancer	0.00164	0.0904	CcSEcCtD
Phenazopyridine—Hepatitis—Octreotide—thymus cancer	0.00151	0.0832	CcSEcCtD
Phenazopyridine—SCN5A—Developmental Biology—DPYSL5—thymus cancer	0.0015	0.0241	CbGpPWpGaD
Phenazopyridine—Visual impairment—Octreotide—thymus cancer	0.00146	0.0802	CcSEcCtD
Phenazopyridine—SCN5A—Cardiac Progenitor Differentiation—KIT—thymus cancer	0.00137	0.0219	CbGpPWpGaD
Phenazopyridine—Dyspepsia—Octreotide—thymus cancer	0.000947	0.052	CcSEcCtD
Phenazopyridine—Gastrointestinal disorder—Octreotide—thymus cancer	0.000929	0.051	CcSEcCtD
Phenazopyridine—Hypersensitivity—Octreotide—thymus cancer	0.000793	0.0436	CcSEcCtD
Phenazopyridine—Pruritus—Octreotide—thymus cancer	0.000761	0.0418	CcSEcCtD
Phenazopyridine—Diarrhoea—Octreotide—thymus cancer	0.000736	0.0405	CcSEcCtD
Phenazopyridine—Vomiting—Octreotide—thymus cancer	0.000684	0.0376	CcSEcCtD
Phenazopyridine—Rash—Octreotide—thymus cancer	0.000678	0.0373	CcSEcCtD
Phenazopyridine—Dermatitis—Octreotide—thymus cancer	0.000678	0.0372	CcSEcCtD
Phenazopyridine—Headache—Octreotide—thymus cancer	0.000674	0.037	CcSEcCtD
Phenazopyridine—Nausea—Octreotide—thymus cancer	0.000639	0.0351	CcSEcCtD
Phenazopyridine—SCN7A—Developmental Biology—AKT1—thymus cancer	0.000213	0.00341	CbGpPWpGaD
Phenazopyridine—SCN11A—Developmental Biology—AKT1—thymus cancer	0.00019	0.00303	CbGpPWpGaD
Phenazopyridine—SCN8A—Developmental Biology—AKT1—thymus cancer	0.000173	0.00278	CbGpPWpGaD
Phenazopyridine—SCN9A—Developmental Biology—AKT1—thymus cancer	0.00014	0.00224	CbGpPWpGaD
Phenazopyridine—SCN3A—Developmental Biology—AKT1—thymus cancer	0.000134	0.00215	CbGpPWpGaD
Phenazopyridine—SCN4A—Developmental Biology—AKT1—thymus cancer	0.000129	0.00206	CbGpPWpGaD
Phenazopyridine—SCN2A—Developmental Biology—AKT1—thymus cancer	0.000129	0.00206	CbGpPWpGaD
Phenazopyridine—SCN1A—Developmental Biology—AKT1—thymus cancer	0.000124	0.00199	CbGpPWpGaD
Phenazopyridine—SCN10A—Developmental Biology—AKT1—thymus cancer	0.000124	0.00199	CbGpPWpGaD
Phenazopyridine—SCN5A—Developmental Biology—AKT1—thymus cancer	8.73e-05	0.0014	CbGpPWpGaD
